RxDoctor Payments Data

Amber Chambers, PA

Physician Assistant · Sioux Falls, SDNPI 1497720254

Payments from drug & device makers

$1,917in general payments, 2019–2025

Across 74 payments — averaging $25.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$538
  • Astellas Pharma US Inc$265
  • Johnson & Johnson$215
  • AbbVie$136
  • 180 Medical, Inc.$116
  • Boston Scientific$90
  • plus $557 from 18 others

What the payments were for

  • Food & beverage$1,82395%
  • Education$945%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,917 in reported general payments places this provider in the 85th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$118,401
Medicare patients
578
Services billed
7,378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron73$34,248
GemtesaVibegron40$19,472
Tamsulosin Hcl134$1,490
Methenamine Hippurate20$780
Solifenacin Succinate21$592
Finasteride47$574
Alfuzosin Hcl ErAlfuzosin Hcl34$313
Cefdinir17$298
Cephalexin39$233
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$149
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$60
Ciprofloxacin Hcl14$53
Tramadol Hcl31$32

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$265$34,24873 claims
Sumitomo Pharma America, Inc.Gemtesa$37$19,47240 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →